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MRI, 1H-MRS, and functional MRI during
and after prolonged nonconvulsive
seizure activity
F. Lazeyras, PhD; O. Blanke, MD; I. Zimine, BSc; J. Delavelle, MD; S.H. Perrig, MD; and M. Seeck, MD
Article abstract—Background: Various structural and functional changes, such as focal edema, blood flow, and metabo-
lism, occur in the cerebral cortex after focal status epilepticus. These changes can be assessed noninvasively by means of
MRI techniques, such as fluid-attenuated inversion recovery (FLAIR), EEG-triggered functional MRI (EEG-fMRI), and
proton MR spectroscopy (MRS). Methods: The authors report on a 40-year-old patient with nonlesional partial epilepsy in
the left posterior quadrant in whom these MRI techniques were applied in an active seizure focus and repeated during a
follow-up of 1 year. Results: FLAIR imaging taken at the time of status epilepticus showed a signal hyperintensity in the
occipital region. 1H-MRS of this cortical region showed elevated lactate, decreased N-acetylaspartate (NAA), and elevated
choline (Cho). In the same region, EEG-fMRI revealed an area of signal enhancement. After seizure control, recovery of
lactate and Cho was observed, whereas the NAA level remained reduced. The structural abnormality demonstrated on
FLAIR disappeared within 3 months. Conclusions: Repetitive MRI with sensitive sequences during clinically critical
periods may disclose the structural correlate in a previously nonlesional epilepsy case. Corresponding to the clinical
evolution, reversible and irreversible focally abnormal metabolism can be determined with 1H-MRS, reflecting both
increased neuronal activity and neuronal damage.
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During the last decade, new MRI methods were de-
veloped that are becoming available to improve the
noninvasive localization of epileptogenic focus. These
recent MRI techniques include the fluid attenuated
inversion recovery sequence (FLAIR),1 which im-
proves the sensitivity of detecting structural changes
associated with hippocampal sclerosis as well as in
remote subcortical and cortical regions in epilepsy.2-4
Another new approach to localize the epileptic fo-
cus is the use of functional MRI (fMRI). Blood oxygen
level dependent (BOLD) fMRI is able to detect blood
flow changes related to neuronal activity and has
been applied in epilepsy using the hemodynamic re-
sponse concomitant to neuronal firing during
seizure.5-7 The aim is to record the EEG while the
patient is in the magnet in order to trigger the fMRI
acquisition with epileptic activity.8 This method pro-
vides images of interictal dysfunction with a high
spatial resolution, allowing a direct comparison with
structural MRI.
Proton MR spectroscopy (1H-MRS) has been an
established tool in clinical epilepsy studies for almost
a decade. It has been used mainly to detect and
quantify N-acetylaspartate (NAA), which is consid-
ered a marker for neuronal integrity. A decrease of
the NAA level indicates neuronal loss or dysfunction
and has been observed in the hippocampus by many
groups.9-11 Other metabolic changes such as an in-
crease of choline-containing compounds (Cho) and
creatine 1 phosphocreatine (Cr) in the hippocampus
have been reported and were attributed to reactive
astrocytis.10 In the neocortex involving epileptic ac-
tivity, metabolite alterations including elevated
glutamine/glutamate signal (glx) and lactate have
been observed as well.12-14
Few studies have used the outlined techniques in
combination to identify the epileptic focus in patient
with the initial diagnosis of nonlesional extratempo-
ral epilepsy. In fact, this patient group is the most
difficult to treat surgically if this line of treatment
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needs to be pursued because of pharmacoresistance.
Furthermore, few follow-up studies are available elu-
cidating the temporal evolution of the anomalies in
each of the described MRI-based techniques. Here
we present a case in which repetitive FLAIR se-
quences, 1H-MRS, and EEG-fMRI acquisition al-
lowed localization of the epileptic focus as well as the
assessment and evolution of metabolic alterations
during a 1-year follow-up.
Patient and methods. Case report. A 40-year-old
right-handed man with a history of complex partial sei-
zures since age 31 experienced a generalized tonic-clonic
seizure followed by brief episodes of simple visual phenom-
ena described as moving color dots in the right visual field.
Rarely intermittent micropsia or palinopsia was reported
as well. Postictally a right hemianopia was observed. The
simple partial visual seizures became more and more fre-
quent, finally evolving to a simple partial status epilepti-
cus. He was admitted to our institution for an evaluation
of his epilepsy at this time. His neurologic examination
was unremarkable. During his first evaluation (36 months
before the current study), he had frequent simple partial
seizures associated with left temporo-occipital discharges
as recorded on EEG. The anatomic spin echo MRI was
normal, whereas PET showed posterior left temporo-
occipital hypometabolism. Two ictal SPECT studies
showed consistent hyperperfusion of the left posterior
quadrant, whereas the interictal SPECT was normal. Thus
a left occipital lobe epilepsy was diagnosed. During this
first evaluation, two 8 mL single-voxel 1H-MRS examina-
tions were also performed using long echo time spin echo
sequence. The position of the voxels was based on seizure
semiology, ictal and interictal EEG, and nuclear imaging
findings. One voxel was located in the mesial occipital lobe
and the other was on the lateral side of the occipital lobe.
Homologous voxels in the right hemisphere served as con-
trol. No metabolic abnormality was detected from the two
left-sided locations when compared to the controls.
Medication was changed from a phenobarbital and phe-
nytoin bitherapy to valproate monotherapy, yielding good
seizure control for 3 years. However, his habitual seizures
recurred, up to the point that nonconvulsive status epilep-
ticus was diagnosed, necessitating a further change in
drug therapy. An increase of his daily valproate dosage
together with the introduction of primidone caused a rapid
control of his seizure disorder. Except for brief episodes of
visual phenomenon in the right visual field without loss of
contact (after visit 2, see below), his seizure disorder re-
sponded well to the new drug treatment for more than 1
year. During this 1-year follow-up period, the patient was
monitored with five MRI and 1H-MRS examinations. We
report findings about this period with the following nam-
ing convention: visit 1 corresponds to the nonconvulsive
status epilepticus period; visit 2, 4 days after; visit 3, 30
days after; visit 4, 90 days after; and visit 5, 1 year after.
fMRI triggered by recurrent simple partial seizures and
interictal discharges was carried out at visit 2.
Informed consent was obtained according to our institu-
tion’s ethical rules.
MRI. 1.5 tesla Eclipse system (Marconi Medical Sys-
tems, Cleveland, OH) with standard head coil was used.
The MRI examination consisted of a FLAIR sequence (in-
version time [TI]/echo time [TE]/repetition time [TR] 1700/
83/7000 msec, echo train length 8, slice thickness 5 mm,
field of view [FOV] 220 mm, acquisition matrix 192 3 256),
a combined EEG-fMRI using single shot EPI (TE/TR 40/
979 msec, flip angle 80°, FOV 250 mm, 11 contiguous 5
mm slices), and a single voxel 1H-MRS using STEAM se-
quence (TE/TR/mixing time [TM] 20/1500/13 msec, voxel
volume 3.4 mL, number of averages 256).
EEG-fMRI acquisition. Sixteen gold-coated silver
scalp electrodes (Neuroscan Inc., Sterling, VA) were ap-
plied with conductive paste according to standard positions
of the 10/20 system. Data were recorded continuously on a
64-channel EEG machine (Deltamed SA, Paris, France)
with a sampling rate of 128 Hz while the patient was
positioned in the MRI machine.
fMRI data acquisition was triggered whenever an epi-
leptic discharge was observed on the EEG recording or if
the patient indicated the occurrence of a simple partial
seizure (“activation” condition). In both cases, EEG rhyth-
Figure 1. Series of axial fluid-attenuated inversion recovery (FLAIR) images obtained during the status epilepticus (a;
visit 1), 4 days later (b; visit 2), 30 days later (c; visit 3), and 90 days later (d; visit 4). During nonconvulsive status epi-
lepticus, the FLAIR images showed diffuse hyperintensity (a, arrow) involving the gray and the white matter. The area of
hyperintensity diminished in 4 days (b), now involving somewhat more the gray matter, and was still visible at day 30
(c). The FLAIR image obtained 90 days after seizure showed complete disappearance of the hyperintense signal (d) and
remained normal up to 1 year after the status.
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mic or isolated spikes and sharp waves were maximal over
the left temporo-occipital regions. A minimum of 15 sec-
onds delay was given between each acquisition to avoid
spin saturation effect. A second set of 40 images was
acquired after injection of 1.5 mg clonazepam that elim-
inated most of the discharges on the EEG (“control”
condition). For this data set, the delay between the two
acquisitions was set to 15 seconds. After motion correc-
tion using the automatic image registration (AIR 3.08)
algorithm,15 the image time course was analyzed by com-
puting the cross-correlation with a step function
(activation/control).16
1H-MRS data reduction. Processing of the spectra was
done with SAGE spectroscopy analysis software (General
Electric Medical Systems, Fremont, CA) and consisted of
low frequency filtering, 1.5 Hz exponential apodization,
zero filling, Fourier transform, and automatic zero order
phase correction. The peak amplitudes were derived after
fitting of the spectra using the Marquardt algorithm of the
SAGE program. The different metabolites were assigned
according to the literature17-18 and the following abbrevia-
tions were used: lipids and/or macromolecules (lip); lactate
(lact); NAA; Cr; Cho; myoinositol (mI). Reference-
normalized concentrations were determined using water as
internal standard assuming constant water concentration
of 110 molar and were corrected for relative proton abun-
dance, saturation effects, and tissue water content.18-19 The
effects of relaxation were not specifically determined, espe-
cially in the lesion, and therefore it was not possible to
convert amplitudes to absolute concentrations. In this arti-
cle, metabolite concentrations are referred to reference-
normalized concentration measurements. Results were
also expressed as ratios to the Cr peak. The contralateral
spectrum was used as control.
Results. Seizure. At the time of the first visit, the pa-
tient experienced frequent simple partial seizures. The
FLAIR image (T2-weighted) revealed a hyperintense sig-
nal without mass effect in the left occipital region; i.e.,
upper calcarine fissure (figure 1a), covering gray and white
matter. The EEG signal recorded inside the magnet
showed focal epileptogenic activity over the temporo-
occipital regions and showed a similar topography as out-
side the magnet. EEG-fMRI showed a distinct region of
activation in the left upper calcarine fissure, concordant
with the hyperintense cortical region seen in the FLAIR
image. The BOLD signal enhancement was around 6%
with a statistical threshold set at p , 0.05 after Bonferroni
correction. 1H-MRS voxels were targeted to investigate
this distinct area. Figure 2 shows the BOLD localization
on two contiguous slices of the seizure superimposed to the
FLAIR image together with the 3.4 mL voxel locations
represented in dotted lines. The corresponding spectra are
shown on figure 3. The spectrum taken at the site of the
lesion shows marked metabolite changes (figure 3b) when
compared to the contralateral spectrum (figure 3a), includ-
ing elevated lactate and reduced NAA (35%). An additional
and previously unreported finding is a marked increase of
Cho and a slight but significant decrease of mI.
Figure 2. Fluid-attenuated inversion recovery (FLAIR) im-
age of two contiguous slices (a and b) obtained during the
status epilepticus with the 1H-MR spectroscopy voxels of
the areas studied shown in dotted lines. The blood oxygen
level dependent signal enhancement is also superimposed
on the image.
Figure 3. Series of 3.4 mL STEAM (echo time 20 msec) spectra obtained during the status epilepticus (visit 1), as well as
4 days (visit 2), 30 days (visit 3), and 90 days after (visit 4). During the status epilepticus (b) the spectrum showed a
marked depletion of N-acetylaspartate (NAA), an increase of lactate and choline-containing compounds (Cho), and a de-
crease of myoinositol (mI) compared to the control spectrum from the contralateral side (a). Lactate, Cho, and mI recovery
is noticed 4 days after status epilepticus (c) and returned to normal at day 30 (d). NAA level remained low through the
time study. The spectrum obtained after 1 year showed similar metabolite levels to the spectra obtained at day 90 (e).
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Serial study. Following the control of his seizure disor-
der, the patient had four consecutive MR examinations
(visits 2 to 5). The FLAIR images obtained at day 4, day
30, day 90, and day 360 showed a progressive return to
normal (figure 1, b through d). At visit 2 (day 4) there was
still a marked hyperintense signal including gray and
white matter in the left calcarine fissure (figure 1b). Thirty
days later (visit 3), there was a marked reduction of hyper-
intense area involving only gray matter (figure 1c), whereas
at day 90 (visit 4), no area of hyperintensity could be de-
tected (figure 1d). One year later (visit 5), the FLAIR im-
age remained normal.
The evolution of MRS spectra obtained at the same time
points is shown in figure 3, c through e. The lactate level
was reduced at day 4 (visit 2) and was undetectable at 30
days. Abnormal NAA values remained low even after 1
year. The Cho and the mI peaks progressively returned to
normal within 30 days. These findings are summarized in
the table, reporting the different metabolite ratios and con-
centrations corresponding to the different time points. Fig-
ure 4 represents the time course of the metabolites to Cr
ratios.
Discussion. In the current report, a patient with
occipital epilepsy and a previously unrevealing rou-
tine MRI showed a focal hyperintensity while experi-
encing frequent habitual seizures. Thus, optimal
timing of follow-up imaging examinations, together
with the use of more sensitive sequences, allowed the
proper identification of the anatomic substrate of the
epileptic focus.
Hyperintense signals in T2-weighted images after
prolonged partial status epilepticus have been ob-
served by different groups in both hippocampal and
neocortical tissue.20-24 The resolution of the signal
changes within 3 months, as seen in our patient, has
been also reported in several other studies.21,22,25 The
signal hyperintensity may or may not be associated
with gadolinium contrast enhancement and does not
exhibit mass effect.23,24 Proposed mechanisms for
these lesions include vasogenic edema reflecting
altered permeability of the vessels in relation to sei-
zures, which results in a breakdown of the blood–
brain barrier and fluid accumulation in the white
matter within the extracellular space. The implica-
tion of the gray matter may reflect a cytotoxic edema
as well.21 In our case, the changes seen in FLAIR
Figure 4. Time series of metabolite to creatine 1 phospho-
creatine (Cr) ratios. The left column represents the mean
and 2 standard deviations of the metabolite levels of four
control spectra obtained independently in the contralateral
occipital cortex. The lactate, choline-containing compounds
(Cho), and myoinositol (mI) levels recovered progressively
within 30 days after the status epilepticus, whereas the
N-acetylaspartate (NAA) level remained low.
Table Metabolite ratios and concentrations
Metabolites Control,* mean 6 2 SD Visit 1, seizure Visit 2, day 4 Visit 3, day 30 Visit 4, day 90 Visit 5, day 360
Ratios
mI/Cr 0.52 6 0.14 0.34 0.50 0.45 0.52 0.58
Cho/Cr 0.42 6 0.11 0.91 0.68 0.64 0.54 0.43
Glx/Cr 0.47 6 0.31 0.32 0.43 0.42 0.39 0.47
NAA/Cr 1.39 6 0.16 0.86 0.76 0.89 0.90 0.86
Lactate/Cr 0.07 6 0.19 0.98 0.41 0.00 0.15 0.29
Concentrations†
mI 4.07 6 1.00 3.11 3.93 3.94 4.49 4.53
Cho 1.26 6 0.30 2.76 1.89 1.88 1.59 1.12
Cr 8.06 6 0.75 9.21 8.06 8.87 8.85 7.94
Glx 1.99 6 1.43 1.54 1.81 1.95 1.82 1.95
NAA 10.76 6 1.90 7.57 6.15 7.58 7.62 6.55
Lactate 0.49 6 1.41 7.86 2.78 0.2 1.17 1.98
* N 5 4 measurements in the homologous contralateral occipital cortex region.
† Reference-normalized concentrations to the water signal, after corrections for proton abundance and relaxation (T1 and T2). A water
concentration of 110 M and a water content of 70% were assumed. The data are expressed in mM.
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outlast the ictal activity, and disappeared between 1
and 3 months post status. Consequently, FLAIR im-
aging should still yield positive results if taken
within 1 month after a period of significant seizure
increase.
The EEG-fMRI results revealed a positive BOLD
effect in the region that matches the localization of
the hyperintense signal in the FLAIR image. This
suggests an increase of the local blood flow as a
consequence of increased epileptic activity, because
the BOLD effect is primarily due to hemodynamic
response as a result of neuronal activity. Note that
the EEG-fMRI study was performed 4 days after the
status epilepticus, whereas the EEG showed still im-
portant interictal abnormalities. As suggested by
other reports, the so-obtained BOLD signal can be
detected in the absence of T2 hyperintensity5,6 and
can be used to guide a more focused exploration of
the suspicious brain region; for instance, the posi-
tioning of the spectroscopy voxel.
As outlined above, a decrease of NAA level indi-
cates neuronal loss or dysfunction, whereas an in-
crease of Cho and Cr reflects probably reactive
astrocytosis. Metabolic changes assessed by 1H-MRS
have been observed in adjacent temporal neocortex
and in extratemporal epileptic areas.10,12-14,26,27 Our
results confirm the high sensitivity of 1H-MRS to
detect epileptic activity in extratemporal cortex.
Nevertheless, the main limitation of single voxel 1H-
MRS used in this study is related to the choice of the
voxel placement, which may be difficult in the ab-
sence of a lesion detected either by structural or
functional MRI. A better anatomic coverage can be
achieved by the use of chemical shift imaging as has
been shown in temporal and extratemporal
epilepsy.12,28
Few 1H-MRS longitudinal descriptions of spectral
anomalies and their changes after prolonged seizure
activity exist. In the current case, the lowest NAA
level was observed at day 4 (see the table). The NAA
time course showed a slight (10%) recovery, but
remained low over the 1-year study period, which
confirms a previous study’s findings.13 However,
short-term NAA changes have been observed as well
and reflect local metabolic dysfunctions rather than
neuronal loss.29 To our knowledge, it is not possible
to differentiate the origin of low NAA values; it
seems that only follow-up measurements provide a
clue whether they represent a transient or persistent
neuronal dysfunction.
We also measured high lactate levels up to 4 days
after the initial event. This represents a highly local-
izing sign of epileptic activity and is consistent with
the hypothesis that lactate is produced locally upon
increased ictal metabolism, as suggested by previous
observations.26,29 Discrete lactate elevations have
also been observed in the visual cortex of healthy
subjects after visual stimulation,30,31 and were attrib-
uted to astrocytic lactate production, which serves as
an important energy source for neurons.32,33 How-
ever, the presence of lactate is also closely tempo-
rally related to the incidence of increased epileptic
discharges. During the acute phase (visits 1 and 2),
the lactate peak was significantly elevated and dis-
appeared between day 4 and day 30 (reduced already
at day 4). Its reduction corresponded well with the
significant clinical improvement as well as the de-
crease of the epileptic discharges. Lactate remained
undetectable for the remaining 1-year follow-up pe-
riod during which the patient had only rare simple
partial seizures. Our findings are consistent with ob-
servations that found lactate only in patients with
seizures occurring immediately before or during the
1H-MRS examination.26 Transient lactate following
seizures in rat models has been observed as well and
suggests that lactate is related to excessive neuronal
activity and not to neuronal damage.29,34
Elevated choline during the ictal phase has not
been reported. Interestingly, although not reported,
some published spectra showed clearly elevated cho-
line (see, for instance, figure 3 in reference 34 and
figure 2 in reference 28). Increased hippocampal cho-
line has been observed in mesiotemporal epilepsy
and has been attributed to gliosis.10,35 Our data show
a recovery of Cho that is too fast (in less than 30
days) to be associated with gliosis. The mobile
choline-containing compounds include choline, ace-
tylcholine, phosphocholine, and glycerophosphocho-
line. There is a distinct interaction between the
different choline moieties.36 Choline, for instance, is
a biochemical precursor for both acetylcholine and
phospholipids. Our 1H-MRS findings of increased
Cho may reflect an increase in acetylcholine and cho-
line, which was observed in rats during seizures in-
duced by convulsant treatments.37,38 Further studies
are needed to investigate the choline changes as as-
sessed by 1H-MRS in relation to seizure.
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